Decriptive study of EDB
Otherdata on EDB will be register
NCT Number: NCT04757727
Dystrophic epidermolysis bullosa is a rare genetic pathology resulting in fragility of the skin and mucous membranes, causing bubbles and wounds following trauma. Scarring is pathological with a tendency to retraction. The gynecological and in particular the vulvovaginal mucous membranes can be affected but no description of any series is available in the literature. Likewise, some of these patients have a sexual and obstetrical life, despite sometimes-severe damage, but again no specific data is available. The investitigator thus wish to carry out a non-interventional multicenter prospective descriptive study. Better knowledge of gynecological semiology in patients with EBD will allow better adaptation of gynecological follow-up, screening for STDs and gynecological cancers, as well as possible specific complications. This study would eventually allow the draw up of recommendations for our gynecologist / obstetrician colleagues.
Looking for future studies?
Notify Me18 year and older
Female
Observational
CHU de NICE, Nice, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
data on EDB will be register
Time frame: 12 months
Adult women (> 18 years old) with hereditary dystrophic epidermolysis bullosa (dominant or recessive) followed at the Nice University Hospital or at the St Louis Hospital of the APHP.
Descriptve evaluation of the recruited population Description of the anatomical and gynecological functional impairment of adult women with dystrophic epidermolysis bullosa.
Centre Hospitalier Universitaire de Nice
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04917874
Collagen Diseases, Congenital Abnormalities
Rancho Santa Margarita, California, United States
View Trial DetailsNCT02579369
Collagen Diseases, Congenital Abnormalities
Seoul, South Korea
View Trial DetailsNCT03183934
Collagen Diseases, Congenital Abnormalities
Seoul, South Korea
View Trial DetailsNCT04491604
Collagen Diseases, Congenital Abnormalities
Rancho Santa Margarita, California, United States
View Trial Details